Innothera

Summary

Innothera is an organization^[1].

Key Facts

• Innothera is in the country of France^[2].
• Innothera is in the country of FR^[3].
• Innothera's instance of is recorded as organization^[4].
• Innothera's headquarters location is recorded as Arcueil^[5].
• Innothera's industry is recorded as pharmaceutical industry^[6].
• Innothera's industry is recorded as holding company activities^[7].
• Innothera's country of origin is recorded as France^[8].
• January 1, 1913 marks the founding of Innothera^[9].
• 1900-01-01 marks the founding of Innothera^[10].
• Innothera's official website is recorded as http://www.innothera.fr/^[11].
• Innothera's director / manager is recorded as Arnaud Gobet^[12].
• Innothera's official name is recorded as INNOTHERA^[13].
• Innothera's legal form is recorded as société par actions simplifiée^[14].
• Innothera's legal form is recorded as 6CHY^[15].

Product Details

The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.

GLEIF Golden Copy — Level 1 entity data

• Legal Entity Identifier (LEI): 969500JR529HOQN11233^[16]

• Registered legal name: Innothera^[17]

• Legal jurisdiction: FR^[18]

• GLEIF entity category: GENERAL^[19]

• Legal form (ISO 20275 ELF): 6CHY^[20]

• Entity status: ACTIVE^[21]

• LEI registration status: LAPSED^[22]

• Entity created: 1900-01-01^[23]

• LEI first registered: 2018-04-26^[24]

• LEI last updated: 2024-05-22^[25]

• LEI next renewal: 2020-07-24^[26]

• Managing LOU: 969500Q2MA9VBQ8BG884^[27]

• Registration authority: RA000189^[28]

• Authority entity ID: 302587662^[29]

• Conformity flag: NON_CONFORMING^[30]

Body

Founding

Recorded inception include January 1, 1913^[9] and 1900-01-01^[10].

Identity

Innothera's official name is recorded as INNOTHERA^[13].

Leadership

Innothera's director / manager is recorded as Arnaud Gobet^[12].

Operations

Innothera's headquarters location is recorded as Arcueil^[5].

Industry

Industries include pharmaceutical industry^[6] and holding company activities^[7].